RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of FATE
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

A very strong day for Fate Therapeutics stock price on Wednesday
(Updated on Mar 27, 2024)

Buy candidate since Mar 27, 2024 PDF

The Fate Therapeutics stock price gained 7.00% on the last trading day (Wednesday, 27th Mar 2024), rising from $6.86 to $7.34. During the last trading day the stock fluctuated 8.86% from a day low at $6.77 to a day high of $7.37. The price has fallen in 5 of the last 10 days and is down by -3.93% for this period. Volume fell on the last day by -265 thousand shares and in total, 2 million shares were bought and sold for approximately $15.22 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 83.43% during the next 3 months and, with a 90% probability hold a price between $12.51 and $17.10 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

FATE Signals & Forecast

A sell signal was issued from a pivot top point on Thursday, March 07, 2024, and so far it has fallen -12.10%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Some positive signals were issued as well, and these may have some influence on the near short-term development. The Fate Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $7.08 and $7.13. A breakdown below any of these levels will issue sell signals. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Fate Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $6.76 and $6.16. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Fate Therapeutics finds support just below today's level at $6.76. If this is broken, then the next support from accumulated volume will be at $6.16 and $5.72.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.600 between high and low, or 8.86%. For the last week, the stock has had daily average volatility of 8.89%.

Our recommended stop-loss: $6.96 (-5.21%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 14 days ago.)

Trading Expectations (FATE) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Fate Therapeutics to open at $7.16, and during the day (based on 14 day Average True Range), to move between $6.68 and $8.00, which gives a possible trading interval of +/-$0.657 (+/-8.95%) up or down from last closing price. If Fate Therapeutics takes out the full calculated possible swing range there will be an estimated 17.90% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $7.43 (1.23%) than the support at $6.76 (7.90%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Fate Therapeutics stock A Buy?

Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 1.753 Buy Candidate Upgraded

Predicted Opening Price for Fate Therapeutics of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$7.16 ( 2.45%) $7.34

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for FATE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 7.76 5.72 %
R2 7.53 2.60 %
R1 7.39 0.670 %
Current price: 7.34
Support S1 6.93 -5.57 %
S2 6.79 -7.50 %
S3 6.56 -10.63 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 7.49 2.04 %
R2 7.46 1.63 %
R1 7.43 1.23 %
Current price 7.34
Support S1 6.76 -7.90%
S2 6.16 -16.08%
S3 5.72 -22.07%

FAQ

What is the symbol for Fate Therapeutics Stock and on which exchange is it traded?
The symbol for Fate Therapeutics is FATE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Fate Therapeutics Stock?
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy Fate Therapeutics Stock?
Fate Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Fate Therapeutics Stock.

What's the current price of Fate Therapeutics Stock?
As of the end of day on the 2024-03-27, the price of an Fate Therapeutics (FATE) share was $7.34.

What is the 52-week high and low for Fate Therapeutics Stock?
The 52-week high for Fate Therapeutics Stock is $8.83 and the 52-week low is $1.63.

What is the market capitalization of Fate Therapeutics Stock?
As of the 2024-03-27, the market capitalization of Fate Therapeutics is 728.403M.

When is the next earnings date for Fate Therapeutics?
The upcoming earnings date for Fate Therapeutics is May 01, 2024.
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT